Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01122771
Recruitment Status : Completed
First Posted : May 13, 2010
Last Update Posted : January 21, 2016
Shaheed Surhawardy Medical College and Hospital
International Centre for Diarrhoeal Disease Research, Bangladesh
Information provided by (Responsible Party):
Drugs for Neglected Diseases